Leaders and laggards Immuneering (NASDAQ:IMRX) shares jumped 22% on August 25 after the clinical-stage oncology company announced a clinical supply agreement with Eli Lilly (NYSE: LLY) for its second-generation KRAS G12C inhibitor, olomorasib (LY3537982)
The researchers say that the results align with advancements in IOL power calculation driven by innovations such as machine learning for parameter optimization, multivariate regression with integrated biometric parameters, and anatomical segmentation of axial length, which collectively address limitations of traditional models reliant on simplified ocular assumptions. 1
There is opportunity to include components such as logo and other branding, high-level instructions for completing the kit, contact and support lines, and QR code or link to instructional videos, and other resources such as general health and wellness education pertaining to the collection kit content
Hou Q, Li S, Li L, Li Y, Sun X, Tian H
Is oral glutathione actually absorbed
Q: How long does it take for CJC-1295 to work
